![Ying Xia Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ying Xia Li
Director/Board Member at Wuhan Canvest Biotechnology Co., Ltd.
Profile
Ying Xia Li is currently a Member-Supervisory Board & Head-Report Center at Wuhan Canvest Biotechnology Co., Ltd.
She started this position in 2020.
Prior to her current job, she graduated from Wuhan University.
Ying Xia Li active positions
Companies | Position | Start |
---|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
![]() Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Director/Board Member | 23/07/2020 |
Training of Ying Xia Li
Wuhan University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Wuhan Canvest Biotechnology Co., Ltd.
![]() Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Health Technology |
- Stock Market
- Insiders
- Ying Xia Li